Pharmacokinetic-pharmacodynamic relationships of apomorphine in patients with Parkinson's disease.

Pharmacokinetic-pharmacodynamic relationships of apomorphine in patients with Parkinson's disease.

Item
http://www.wikidata.org/entity/Q33747108
Drug Repositioning for Cancer Therapy Based on Large-Scale Drug-Induced Transcriptional SignaturesEffect of apomorphine on cognitive performance and sensorimotor gating in humansPredictability of intranasal pharmacokinetics in man using pre-clinical pharmacokinetic data with a dopamine 3 receptor agonist, PF-219061.Regulation of dopaminergic function: an [18F]-DOPA PET apomorphine challenge study in humans.S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosisDopamine agonists in Parkinson's disease.Update on apomorphine for the rapid treatment of hypomobility ("off") episodes in Parkinson's disease.Treatment of Parkinson's disease in the advanced stage.What is the best treatment for fluctuating Parkinson's disease: continuous drug delivery or deep brain stimulation of the subthalamic nucleus?Anti-Parkinson's disease drugs and pharmacogenetic considerations.Orodispersible sublingual piribedil to abort OFF episodes: a single dose placebo-controlled, randomized, double-blind, cross-over study.Inhaled dry powder apomorphine (VR040) for 'off ' periods in Parkinson's disease: an in-clinic double-blind dose ranging study.Pharmacological Insights into the Use of Apomorphine in Parkinson's Disease: Clinical Relevance.Efficacy of oral lipid-based formulations of apomorphine and its diester in a Parkinson's disease rat model.Dopamine receptor agonist treatment for idiopathic dystonia: A reappraisal in humans and mice.
P2860

Pharmacokinetic-pharmacodynamic relationships of apomorphine in patients with Parkinson's disease.

Item
http://www.wikidata.org/entity/Q33747108
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Pharmacokinetic-pharmacodynami ...... ents with Parkinson's disease.
@ast
Pharmacokinetic-pharmacodynami ...... ents with Parkinson's disease.
@en
type
label
Pharmacokinetic-pharmacodynami ...... ents with Parkinson's disease.
@ast
Pharmacokinetic-pharmacodynami ...... ents with Parkinson's disease.
@en
altLabel
Pharmacokinetic-Pharmacodynami ...... ents with Parkinson??s Disease
@en
prefLabel
Pharmacokinetic-pharmacodynami ...... ents with Parkinson's disease.
@ast
Pharmacokinetic-pharmacodynami ...... ents with Parkinson's disease.
@en
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P921
P356
P1433
P1476
Pharmacokinetic-pharmacodynami ...... ients with Parkinson's disease
@en
P2093
P2888
P304
P31
P356
10.2165/00003088-199937030-00004
P433
P478
P50
P577
P6179
P698
P921